| scholarly article | Q13442814 |
| P2093 | author name string | Toshiaki Tsubota | |
| Kazuo Ryoke | |||
| Hiroyuki Oka | |||
| Keita Kanki | |||
| Goshi Shiota | |||
| Junya Azumi | |||
| Minoru Morimoto | |||
| Noriko Itaba | |||
| Satoshi Yokogi | |||
| P2860 | cites work | Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice | Q41136479 |
| Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. | Q53386271 | ||
| Reduction in lactate accumulation correlates with differentiation-induced terminal cell division of leukemia cells* | Q53496834 | ||
| Hepatic differentiation of human bone marrow-derived UE7T-13 cells: Effects of cytokines and CCN family gene expression. | Q53541075 | ||
| Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation. | Q53596106 | ||
| Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol | Q70174475 | ||
| Acute promyelocytic leukemia | Q70772271 | ||
| Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition | Q71099781 | ||
| Cancer stem cells | Q80312237 | ||
| Profiling early head and neck cancer | Q81348453 | ||
| Wnt/beta-catenin signaling and small molecule inhibitors | Q24597197 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| 5-Fluorouracil: mechanisms of action and clinical strategies | Q28201937 | ||
| The mutational landscape of head and neck squamous cell carcinoma | Q29614654 | ||
| Tumour heterogeneity and cancer cell plasticity | Q29617990 | ||
| Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 | ||
| Heterogeneity in cancer: cancer stem cells versus clonal evolution | Q29622839 | ||
| Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex | Q31038919 | ||
| Notch inhibitors for cancer treatment | Q34330869 | ||
| Cancer stem cell plasticity and tumor hierarchy | Q34459650 | ||
| Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update | Q35904534 | ||
| Polar/apolar compounds induce leukemia cell differentiation by modulating cell-surface potential | Q36379695 | ||
| Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
| Interactions between Hedgehog proteins and their binding partners come into view | Q37789106 | ||
| Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways | Q37820099 | ||
| The molecular biology of head and neck cancer | Q37821229 | ||
| How to manage acute promyelocytic leukemia | Q37994088 | ||
| A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells | Q38298128 | ||
| P433 | issue | 2 | |
| P921 | main subject | fluorouracil | Q238512 |
| oral squamous cell carcinoma | Q18553522 | ||
| P304 | page(s) | 93-99 | |
| P577 | publication date | 2016-06-29 | |
| P1433 | published in | Yonago Acta Medica | Q15765174 |
| P1476 | title | Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population | |
| P478 | volume | 59 |
| Q48898012 | CDGSH Iron Sulfur Domain 2 Activates Proliferation and EMT of Pancreatic Cancer Cells via Wnt/β-Catenin Pathway and Has Prognostic Value in Human Pancreatic Cancer |
| Q88105265 | Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges |
| Q91651955 | Role of Wnt/β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer |
| Q99551780 | The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells |
Search more.